Growth Metrics

Core Scientific (CORZ) Change in Accured Expenses (2020 - 2026)

Core Scientific has reported Change in Accured Expenses over the past 7 years, most recently at -$16.4 million for Q1 2026.

  • Quarterly results put Change in Accured Expenses at -$16.4 million for Q1 2026, down 703.28% from a year ago — trailing twelve months through Mar 2026 was -$36.5 million (down 344.08% YoY), and the annual figure for FY2025 was -$17.4 million, down 1025.53%.
  • Change in Accured Expenses reached -$16.4 million in Q1 2026 per CORZ's latest filing, up from -$42.3 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $117.4 million in Q4 2023 and bottomed at -$42.3 million in Q4 2025.
  • Median Change in Accured Expenses over the past 5 years was $1.4 million (2024), compared with a mean of $6.8 million.
  • The largest annual shift saw Change in Accured Expenses tumbled 1042.49% in 2024 before it skyrocketed 2409.47% in 2025.
  • Over 5 years, Change in Accured Expenses stood at $17.5 million in 2022, then skyrocketed by 571.9% to $117.4 million in 2023, then crashed by 60.17% to $46.8 million in 2024, then tumbled by 190.56% to -$42.3 million in 2025, then soared by 61.36% to -$16.4 million in 2026.
  • Business Quant data shows Change in Accured Expenses for CORZ at -$16.4 million in Q1 2026, -$42.3 million in Q4 2025, and $34.7 million in Q3 2025.